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Background & Objectives:  Leptospirosis is an emerging infectious disease and is 
considered to be the most widespread zoonotic disease in the world. The outer membrane 
proteins play a crucial role in the process of adaptation by facilitating interactions between 
bacterial cells and its host. One such outer membrane proteins, lipl32 has been observed to be 
highly immunodominant antigen during human leptospirosis. The LipL32 is the major 
leptospiral outer membrane lipoprotein expressed during leptospiral infections. Antigenic 
characterization of the members of the species Leptospira interrogans is a necessary step 
towards to understanding the interactions between leptospires and the immune system.The 
aim of this study was molecular cloning and sequence analysis of  the gene encoding LipL32 
of Leptospira interrogans vaccinal Serovars in Iran. 
Methods: Leptospira interrogans vaccinal serovars canicola (RTCC2805) grippotyphosa 
(RTCC2808), serjoe hardjo(RTCC2821) were used in this study which obtained from the 
Leptospira Reference Laboratory, Razi Vaccine and Serum Research Institute, Karaj, Iran. 
The bacteria were subcultured into the selective culture medium EMJH. The genomic DNA 
was extracted by standard Phenol-Chlorophorm methods. The specific primers for 
proliferation of lipl32 gene were designed. The lipl32 gene was amplified and cloned into a 
cloning vector plasmid and transformed in competent E. coli JM 107cells. Recombinant 
plasmid was isolated from cells by kit (Roche). 
Results: PCR amplification of the lipl32 gene using the designed primers resulted in an 
835bp lipl32 gene product. The amplified gene was cloned in pTZ57R/T vector and 
transformed into E.coli (JM107) cells. The confirmation of the recombinants was made by 
picking the white colonies and carrying out colony PCR amplification of the gene. The 
sequence was deposited in the Gen Bank database. The percentage identity and divergence 
among different leptospiral serovars was deduced using the Blast programme. In our study, 
nucleotide sequencing results showed that gene encoding LipL32 was highly conserved 
among various pathogenic Leptospira strains (>94% Identity) 
Conclusion: In conclusion, the cloned gene could be further used for expression of 
recombinant protein for serodiagnosis and also can be a good candidate for recombinant 
vaccine against leptospirosis. 
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